Quantcast

Latest Raloxifene Stories

2004-12-01 06:00:13

Research and Markets (http://www.researchandmarkets.com/reports/c10315) has announced the addition of Commercial Insight: Osteoporosis and HRT - Novel Osteoporosis Drugs Counter Generic Threat While HRT Players Regroup and Move Forward to their offering The osteoporosis and HRT market was valued at $8.3 billion in 2003 and is forecast to grow to $17.9 billion by 2014, driven by a number of novel osteoporosis drug launches before 2009. Since the Women's Health Initiative (WHI), the HRT...

2004-11-30 18:00:11

A U.S. study of raloxifene found women had more than a 50 percent reduction in breast cancer incidence beyond the first four years of treatment. The Multiple Outcomes of Raloxifene Evaluation, or MORE trial, found that in postmenopausal women with osteoporosis, four years of raloxifene -- under the brand name Evista -- was associated with a 72 percent reduction in breast cancer incidence compared with a placebo. In the Continuing Outcomes Relevant to Evista, or CORE trial, more than...

2004-11-30 18:00:11

TUESDAY, Nov. 30 (HealthDayNews) -- If you're taking raloxifene (Evista) because you have osteoporosis, a new study finds a probable added benefit: The drug may also significantly reduce your risk of developing breast cancer. The study, which appears in the Dec. 1 issue of the Journal of the National Cancer Institute, found that women taking raloxifene for eight years had a 59 percent lower risk of invasive breast cancer and a 66 percent lower risk of developing estrogen-receptor positive...

2004-11-26 18:00:09

Dr. Jim Mitterando Q - I am 61 years old. Should I have a bone density test for osteoporosis and take calcium pills? A - Diagnosing and treating osteoporosis (thin bones) is somewhat controversial with many opinions and not much long-term data. Everybody's bones weaken as they age, but certain choices and habits accelerate the process. These include: Inactivity Not getting enough calcium and vitamin D Smoking Drinking too much alcohol Using certain medications, such as steroids...


Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'